Mira F.
- Country
- The Netherlands
- Department
- Department of medical oncology
Research Overview
- Phase 3 Study of Vepugratinib and Combination Therapy in Adults with Untreated FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
- Phase II Randomized Trial of Preoperative Nivolumab With or Without Relatlimab in Stage II-IIIa Muscle-Invasive Urothelial Bladder Cancer
- C5731001 - An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)
Data & Insights
Has run more than one trial at 87 of 246 partner sites.
Specializations
Urothelial Cancer Treatment
The investigator specializes in advancing treatment options for patients with urothelial carcinoma, with particular emphasis on novel therapeutic approaches for different disease stages.
- Advanced Urothelial Cancer
- HER2-Expressing Tumors
- First-line Treatment Strategies
Their research encompasses targeted therapy combinations and immunotherapeutic approaches in urothelial cancer management.
Immunotherapy Innovation
The investigator focuses on developing immunotherapy-based treatments for bladder cancer, particularly exploring novel combination approaches.
- Neo-adjuvant Immunotherapy
- Muscle-Invasive Disease
- Combination Therapy Approaches
Their work includes evaluation of immune checkpoint inhibitor combinations in early-stage urothelial cancer treatment.
Precision Medicine
The investigator's research extends to personalized treatment approaches in urothelial cancer, with specific attention to molecular targeting.
- Biomarker-Driven Treatment
- Stage-Specific Therapy
- Treatment Optimization
Their work involves studying targeted therapeutic strategies based on specific molecular characteristics of urothelial tumors.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.